This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Exocrine pancreatic insufficiency (EPI) is a condition in which the pancreas does not produce enough of the digestive enzymes needed to break down food. This can lead to malabsorption of nutrients, resulting in diarrhea, abdominal bloating and pain, weight loss, and fatigue. The condition is caused by damage to the cells that produce the enzymes, which can be due to a variety of causes including chronic pancreatitis, cystic fibrosis, autoimmune disorders, genetic disorders, or a lack of certain vitamins or minerals. Treatment of EPI includes taking digestive enzyme supplements to replace the missing enzymes, as well as dietary changes to reduce the amount of fat, fiber, and lactose in the diet. Additionally, taking a multivitamin and mineral supplement may help to replenish any deficiencies. EPI can be a very difficult condition to live with and can have a significant impact on quality of life. Symptoms can range from mild to severe and can be debilitating in some cases. It is important to talk to your doctor if you have any signs or symptoms of EPI, as early diagnosis and treatment can help to minimize symptoms and improve quality of life. Your doctor may order blood tests, imaging studies, or endoscopic tests to diagnose EPI and determine the underlying cause. Treatment options will depend on the cause, but may include dietary changes, digestive enzyme supplements, vitamins and minerals, and medications to reduce inflammation or improve digestion. With proper treatment, most people with EPI can live a healthy and active life.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States